This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Cummings, J., McArdle, C. Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug. Br J Cancer 53, 835–838 (1986). https://doi.org/10.1038/bjc.1986.141
Issue date:
DOI: https://doi.org/10.1038/bjc.1986.141
This article is cited by
-
Anti-cancer effects of novel doxorubicin prodrug PDOX in MCF-7 breast cancer cells
Journal of Huazhong University of Science and Technology [Medical Sciences] (2014)
-
Gold nanorods mediated controlled release of doxorubicin: nano-needles for efficient drug delivery
Journal of Materials Science: Materials in Medicine (2013)
-
Folate-decorated chitosan/doxorubicin poly(butyl)cyanoacrylate nanoparticles for tumor-targeted drug delivery
Journal of Nanoparticle Research (2012)
-
Functionalized Micellar Systems for Cancer Targeted Drug Delivery
Pharmaceutical Research (2007)
-
Alteration of the Pharmacokinetics of COL-3, a Matrix Metalloproteinase Inhibitor, Due to Acute Gastrointestinal Toxicity of Doxorubicin
Pharmaceutical Research (2005)